$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Repare Therapeutics Inc. (NASDAQ: RPTX)

Core Insights - Class Action Attorney Juan Monteverde's firm, Monteverde & Associates PC, is investigating Repare Therapeutics Inc. regarding its sale to XenoTherapeutics, Inc. [1] - Upon closing the proposed transaction, Repare shareholders are expected to receive a cash payment of $1.82 per share, along with a non-transferable contingent value right for additional cash payments under certain conditions [1] Company Overview - Monteverde & Associates PC is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report and has a successful track record in recovering money for shareholders [1][2] - The firm operates from the Empire State Building in New York City and specializes in national class action securities litigation [2] Legal Context - The investigation into Repare Therapeutics Inc. raises questions about the fairness of the proposed deal for shareholders [1] - The firm encourages shareholders with concerns to reach out for additional information [3]